Popular Press

“We know that there is bad stuff that accumulates in blood, in the blood of old people. So we’d like to identify those, pick out the most essential ones. and remove them,” explained Professor Michael Conboy

In the new study recently reported in Nature Biomedical Engineering, Irina Conboy and Niren Murthy at the University of California, Berkeley, decided to try a delivery vehicle they call CRISPR-Gold [1].

In the new study, research lead by the laboratories of Berkeley bioengineering professors Niren Murthy and Irina Conboy demonstrated that their novel approach, called CRISPR-Gold

"Listen to hear about the Conboys’ remarkable research, and its potential future implications for prevention of aging and degenerative disease."

"The researchers were the first in the field of aging research to study the effect of blood transfer between two separate organisms, said collaborating campus researcher Michael Conboy, who is married to Irina."

“A hot fad today may not survive tomorrow, so be conservative on what you try at home in order to live healthier and longer,” says Michael.

"Conboy's research team is ultimately interested in applications beyond just maintaining healthy muscles. For instance, they are also investigating whether oxytocin could become a viable alternative to hormone replacement therapy to impede the symptoms of male and female aging."

"An already FDA-approved molecule could be adapted to fight aging of a number of tissues," study researcher Irina Conboy, also of UC Berkeley, told Live Science.